Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake (Q36985063)

17 August 2017

1 reference

title

Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake (English)

1 reference

17 August 2017

Baker M

1

1 reference

17 August 2017

Parton T

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

37

1 reference

17 August 2017

issue

10-11

1 reference

17 August 2017

page(s)

1110-1134

1 reference

An evaluation of the in vitro metabolism data for predicting the clearance and drug-drug interaction potential of CYP2C9 substrates

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Effects of serum albumin and liver cytosol on CYP2C9- and CYP3A4-mediated drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Rapid screening of small ligand affinity to human serum albumin by an optical biosensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

The complexities of hepatic drug transport: current knowledge and emerging concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Prediction of pharmacokinetic properties using experimental approaches during early drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface- and solution-based biophysical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Albumin helps mediate removal of taurocholate by rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Isolation and characterization of the Xenopus oocyte plasma membrane: a new method for studying activity of water and solute transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Molecular characterization and inhibition of amanitin uptake into human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

The roles of transporters and enzymes in hepatic drug processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Impact of drug transporter studies on drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Influence of albumin on the net sinusoidal efflux of the organic anion dibromosulfophthalein from rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Administration of Escherichia coli endotoxin to rat increases liver mass and hepatocyte volume in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Drug-induced phospholipidosis: issues and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Enterohepatic circulation: physiological, pharmacokinetic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Estimating the Dimension of a Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

The pivotal role of hepatocytes in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Effects of uremic toxins on hepatic uptake and metabolism of erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Development and validation of a method to determine the unbound paclitaxel fraction in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Dissociation from albumin: a potentially rate-limiting step in the clearance of substances by the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Measurement and analysis of unbound drug concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Uptake of organic anions by isolated rat hepatocytes. A classification in terms of ATP-dependency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

Biosensor Analysis of the Interaction between Immobilized Human Serum Albumin and Drug Compounds for Prediction of Human Serum Albumin Binding Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250701658296

10.1080/00498250701658296

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference